Improving the lives of millions by
unlocking the full potential of Liquid Biopsy
Unlocking the full potential of cfDNA
BIOCAPTIVA has unveiled their innovative solution, msX™, a series of polymer coatings designed to effectively extract cell-free DNA (cfDNA) from both biological and non-biological fluids. This groundbreaking technology offers a versatile platform capable of coating any liquid-accessible substrate. By binding cfDNA without limitations on sample volume and without succumbing to biofouling, msX™ stands out as a game-changer in the field. What sets msX™ apart is its ability to operate additive-free, thus safeguarding sample integrity—an essential feature for applications requiring multi-ohmic capabilities. The extracted cfDNA is of superior quality, facilitating streamlined and reproducible workflows. With msX™, BioCaptiva has paved the way for a new era in DNA extraction technology.
Up to 100x more cfDNA capture
BIOCAPTIVA have created BioCaptis, a new medical device to help improve cancer detection through dramatically increasing the amount of cfDNA through the use of apheresis for better diagnostics compared to traditional methods. This advancement allows for more accurate and sensitive tests without the need for amplification or deep sequencing. Ultimately, it enhances genome analysis for more precise clinical decisions in cancer treatment.